Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Drugs Fut 2006, 31(8): 685
ISSN 0377-8282
Copyright 2006 Clarivate
CCC: 0377-8282
DOI: 10.1358/dof.2006.031.08.1008656
 
 
GABAA receptors as targets for different classes of drugs
Sieghart, W.
 
 
GABAA receptors are the major inhibitory transmitter receptors in the brain and are the site of action of many clinically important drugs that modulate anxiety, excitability of the brain, feeding and drinking behavior, circadian rhythms, cognition, vigilance, learning and memory. Evidence has accumulated for the existence of a multiplicity of GABAA receptor subtypes with distinct regional, cellular and subcellular distribution in the brain. Each of these receptors has a distinct structure and thus also exhibits distinct pharmacological properties. Drugs selectively interacting with these receptor subtypes should therefore exert highly selective actions. This conclusion was recently supported by evidence indicating that different receptor subtypes mediate different actions of drugs. This review discusses recent progress in the development of GABAA receptor subtype-selective drugs, as well as recent structural information indicating that these receptors contain a multiplicity of possible binding pockets that could become targets for the development of novel drugs with subtype-specific actions. Targeting drugs to GABAA receptor subtypes holds promise for the treatment of various diseases with a reduced incidence of side effects. In addition, therapeutic applications beyond those of classical benzodiazepines may emerge for drugs specifically enhancing or reducing the activity of minor GABAA receptor subtypes located only at certain neurons.


Full Text: HTMLPDF 
 
  



© Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy